DNA delivery from polymer matrices for tissue engineering

Nature Biotechnology

Volumn 17, Issue 6, 1999, Pages 551-554

  Shea, Lonnie D ^a   Smiley, Elizabeth ^b   Bonadio, Jeffrey ^b   Mooney, David J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Gene therapy; PDGF; Plasmid DNA; Poly(lactide co glycolide); Tissue engineering

Indexed keywords

BETA GALACTOSIDASE; COPOLYMER; PLASMID DNA; PLATELET DERIVED GROWTH FACTOR; POLYGLACTIN;

ANGIOGENESIS; ARTICLE; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; GENETIC TRANSFECTION; PLASMID; PRIORITY JOURNAL;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL LINE; DNA; GENE TRANSFER TECHNIQUES; HUMANS; LACTIC ACID; PLASMIDS; PLATELET-DERIVED GROWTH FACTOR; POLYGLYCOLIC ACID; POLYMERS; RATS; RATS, INBRED LEW;

EID: 0033017213     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/9853     Document Type: Article

References (18)

1. Langer, R. & Vacanti, J.P. Tissue engineering. Science 260, 920-926 (1993).
2. Kim, B.S. & Mooney, D.J. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol.16,224-230 (1998).
3. Mooney, D.J. et al. Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J. Biomed. Mater. Res. 37, 413-420 (1997).
4. Deuel, T.F. in: Principles of tissue engineering (eds Lanza, R.P., Langer, R. & Chick W.L) 133-150 (Academic, San Diego, 1997).
5. Langer, R. New methods of drug delivery. Science 249, 1527-1533 (1992).
6. Jong, Y.S. et al. Controlled release of plasmid DNA. J. Cont. Rel. 47, 123-134 (1997) [Not In Index Medicus Please Spell Out]
7. Labhasetwar, V., Bonadio, J., Goldstein, S., Chen, W. & Levy, R.J. A DNA controlled-release coating for gene transfer: transfection in skeletal and cardiac muscle. J. Pharm. Sci. 87, 1347-1350 (1998).
8. Ledley, F.D. Pharmaceutical approach to somatic gene therapy. Pharm. Res. 13, 1595-1614 (1996).
9. Giannobile, W.V. Periodontal tissue engineering by growth factors. Bone 19, 23S-37S (1996).
10. Harris, L.D., Kim, B.S. & Mooney, D.J. Open pore biodegradable matrices formed with gas foaming. J. Biomed. Mat. Res. 42, 396-402 (1998).
11. Wong, W.H. & Mooney D.J. in Synthetic biodegradable polymer scaffolds (eds Atala, A. & Mooney, D.J.) 51-82 (Birkhausen, Boston; 1997).
12. Raines, E.W. & Ross, R. in Biology of platelet-derived growth factor (eds Westermark, B. & Sorg, C.) 74-114 (Karger, Switzerland; 1993).
13. Peters, M.C. & Mooney, D.J. in Tissue engineering for therapeutic use 2. (eds Ikada, Y. & Enomoto, S.) 55-65 (Elsevier, Amsterdam; 1998).
14. Langer, R. Drug delivery and targeting. Nature 392S, 5-10 (1998).
15. Hedley, M.L. Curley, J. & Urban, R. Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat. Med. 4, 365-368 (1998).
16. Nor, J.E., Christensen, J., Mooney, D.J. & Polverini, P. VEGF enhances the survival of endothelial cells and sustains angiogenesis by inducing expression of Bcl-2. Am. J. Pathol. 154, 375-384 (1999).
17. Stein, G.S., Lian, J.B., Stein, J.L, Van Wijnen, A.J. & Montecino, M. Transcriptional control of osteoblast growth and differentiation. Physiol. Rev. 76, 593-629 (1996).
18. Fang, J. et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Nat. Acad. Sci.USA 93, 5753-5758 (1996).